Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boca Raton, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Inmune Bio, Inc. has filed 590 SEC EDGAR filings since 13 Jul 2017

SEC filing history

Showing 201-225 of 590 matching filings.

Per page
25
Current page
9
8-K File 001-38793

CURRENT REPORT

Filing date
20 Apr 2023
Reporting date
17 Apr 2023
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
11 Apr 2023
Reporting date
11 Apr 2023
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2023
Reporting date
17 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
15 Mar 2023
Reporting date
15 Mar 2023
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
03 Mar 2023
Reporting date
02 Mar 2023
Next action
Verify source filing
10-K File 001-38793

ANNUAL REPORT

Filing date
02 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
22 Feb 2023
Reporting date
21 Feb 2023
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
22 Feb 2023
Reporting date
16 Feb 2023
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90859

SC 13G

Filing date
15 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
10 Feb 2023
Reporting date
08 Feb 2023
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
25 Jan 2023
Reporting date
25 Jan 2023
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
22 Dec 2022
Reporting date
22 Dec 2022
Next action
Verify source filing
8-A12B/A File 001-38793

AMENDMENT NO. 2 TO FORM 8-A12B

Filing date
12 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38793

CURRENT REPORT

Filing date
12 Dec 2022
Reporting date
09 Dec 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .